BiomX Inc. — Form D
BiomX Inc. of NESS ZIONA, L3, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-01. The offering totals $61.5M, of which $61.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-04-01
- Form: D
- Accession: 0001213900-24-028241
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $61.5M
- Amount sold: $61.5M
- Investors: 34
- Date of first sale: 2024-03-15
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-509186
Issuer
- Name: BiomX Inc.
- CIK: 0001739174
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 22 EINSTEIN STREET, FLOOR 4, NESS ZIONA, L3, 7414003
- Phone: +972 723942377
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Jesse Goodman | Director | Ness Ziona, L3 |
| Russell Greig | Director | Ness Ziona, L3 |
| Jonathan Leff | Director | Ness Ziona, L3 |
| Gregory Merril | Director | Ness Ziona, L3 |
| Alan Moses | Director | Ness Ziona, L3 |
| Jonathan Solomon | Director | Ness Ziona, L3 |
| Edward Williams | Director | Ness Ziona, L3 |
| Merav Bassan | Executive Officer | Ness Ziona, L3 |
| Avi Gabay | Executive Officer | Ness Ziona, L3 |
| Assaf Oron | Executive Officer | Ness Ziona, L3 |
| Jonathan Solomon | Executive Officer | Ness Ziona, L3 |
| Marina Wolfson | Executive Officer | Ness Ziona, L3 |
| Paul Sekhri | Director | New York, NY |
| Lynne Sullivan | Director | Ness Ziona, L3 |
| Jonas Grossman | Director | Ness Ziona, L3 |
| Lynne Eitan Sullivan | Director | Ness Ziona, L3 |
| Gbola Amusa | Director | Ness Ziona, L3 |
| Marina Eitan Wolfson | Executive Officer | Ness Ziona, L3 |
| Jonathan Eitan Solomon | Director | Ness Ziona, L3 |
| Jonathan Eitan Solomon | Executive Officer | Ness Ziona, L3 |
| Sailaja Puttagunta | Executive Officer | Ness Ziona, L3 |
| Eddie Williams | Director | Ness Ziona, L3 |
| Susan Blum | Director | Ness Ziona, L3 |
Other filings by this issuer (4)
More